JP2015533511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015533511A5 JP2015533511A5 JP2015541130A JP2015541130A JP2015533511A5 JP 2015533511 A5 JP2015533511 A5 JP 2015533511A5 JP 2015541130 A JP2015541130 A JP 2015541130A JP 2015541130 A JP2015541130 A JP 2015541130A JP 2015533511 A5 JP2015533511 A5 JP 2015533511A5
- Authority
- JP
- Japan
- Prior art keywords
- gram
- negative bacterium
- pneumoniae
- gene
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723408P | 2012-11-07 | 2012-11-07 | |
| US61/723,408 | 2012-11-07 | ||
| PCT/EP2013/073266 WO2014072405A1 (en) | 2012-11-07 | 2013-11-07 | Production of recombinant vaccine in e. coli by enzymatic conjugation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018186302A Division JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015533511A JP2015533511A (ja) | 2015-11-26 |
| JP2015533511A5 true JP2015533511A5 (https=) | 2016-12-22 |
| JP6412875B2 JP6412875B2 (ja) | 2018-10-24 |
Family
ID=49552366
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015541130A Expired - Fee Related JP6412875B2 (ja) | 2012-11-07 | 2013-11-07 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
| JP2018186302A Expired - Fee Related JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018186302A Expired - Fee Related JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150273043A1 (https=) |
| EP (3) | EP3508579B1 (https=) |
| JP (2) | JP6412875B2 (https=) |
| KR (1) | KR20150079964A (https=) |
| CN (1) | CN105008539B (https=) |
| AU (2) | AU2013343520B2 (https=) |
| BR (1) | BR112015010283A8 (https=) |
| CA (2) | CA2889767C (https=) |
| EA (1) | EA201590705A1 (https=) |
| ES (3) | ES2882282T3 (https=) |
| IL (1) | IL238586A0 (https=) |
| MX (1) | MX366912B (https=) |
| SG (1) | SG11201503308XA (https=) |
| TR (1) | TR201903066T4 (https=) |
| WO (1) | WO2014072405A1 (https=) |
| ZA (1) | ZA201503097B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2501406T3 (https=) * | 2009-11-19 | 2018-05-19 | ||
| MX371513B (es) | 2013-10-11 | 2020-01-31 | Glaxosmithkline Biologicals Sa | Metodos de modificacion de celulas huespedes. |
| WO2015124769A1 (en) | 2014-02-24 | 2015-08-27 | Glycovaxyn Ag | Novel polysaccharide and uses thereof |
| CA2945542C (en) * | 2014-04-17 | 2024-03-05 | Glycovaxyn Ag | Modified host cells and uses thereof |
| WO2016020499A2 (en) | 2014-08-08 | 2016-02-11 | Glycovaxyn Ag | Modified host cells for use in bioconjugate production |
| ES3039659T3 (en) * | 2015-02-26 | 2025-10-23 | Vaxnewmo Llc | Acinetobacter o-oligosaccharyltransferases and uses thereof |
| GB201518668D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Immunogenic Comosition |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| CN105963691B (zh) * | 2016-07-03 | 2020-05-01 | 查文娟 | 一种肺炎链球菌疫苗 |
| CN106929573B (zh) * | 2017-02-21 | 2020-06-09 | 南开大学 | 对嗜肺军团菌O12型的wzm和wecA基因特异的核苷酸序列及其应用 |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| GB201712678D0 (en) * | 2017-08-07 | 2017-09-20 | Glaxosmithkline Biologicals Sa | Process for the manipulation of nucleic acids |
| WO2019043245A1 (en) * | 2017-09-04 | 2019-03-07 | London School Of Hygiene And Tropical Medicine | MICROBIAL CELLS EXPRESSING STREPTOCOCCAL SERROTYPES |
| US11235046B2 (en) | 2017-11-04 | 2022-02-01 | Nevada Research & Innovation Corporation | Immunogenic conjugates and methods of use thereof |
| GB201721576D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
| GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
| JP2021528059A (ja) | 2018-06-16 | 2021-10-21 | ヴァックスニューモ エルエルシーＶａｘｎｅｗｍｏ Ｌｌｃ | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
| US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| EP3650044A1 (en) * | 2018-11-06 | 2020-05-13 | ETH Zürich | Anti-glycan vaccines |
| US12350342B2 (en) | 2018-12-21 | 2025-07-08 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
| IL286467B2 (en) | 2019-03-18 | 2026-02-01 | Janssen Pharmaceuticals Inc | Methods for producing bioconjugates of polysaccharides E. coli o-antigen, preparations thereof and methods for using them |
| EP3770269A1 (en) | 2019-07-23 | 2021-01-27 | GlaxoSmithKline Biologicals S.A. | Quantification of bioconjugate glycosylation |
| CN111518738B (zh) * | 2020-05-08 | 2022-02-08 | 徐州海润生物科技有限公司 | 重组卡介苗及其制备方法和应用 |
| CN112369722B (zh) * | 2020-05-08 | 2023-03-17 | 湖北中烟工业有限责任公司 | 加热不燃烧装置和温度控制方法 |
| WO2021255684A1 (en) * | 2020-06-18 | 2021-12-23 | Glaxosmithkline Biologicals Sa | Shigella-tetravalent (shigella4v) bioconjugate |
| WO2021259743A2 (en) | 2020-06-25 | 2021-12-30 | Glaxosmithkline Biologicals Sa | Vaccine |
| AU2021342797B2 (en) | 2020-09-17 | 2024-02-08 | Janssen Pharmaceuticals, Inc. | Multivalent vaccine compositions and uses thereof |
| US12138302B2 (en) | 2020-10-27 | 2024-11-12 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| US12357681B2 (en) | 2020-12-23 | 2025-07-15 | Pfizer Inc. | E. coli FimH mutants and uses thereof |
| WO2023118033A1 (en) | 2021-12-22 | 2023-06-29 | Glaxosmithkline Biologicals Sa | Vaccine |
| GB202302579D0 (en) | 2023-02-23 | 2023-04-12 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| WO2025172892A1 (en) | 2024-02-16 | 2025-08-21 | Glaxosmithkline Biologicals Sa | Modified proteins and methods |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995031548A1 (en) * | 1994-05-16 | 1995-11-23 | The Uab Research Foundation | Streptococcus pneumoniae capsular polysaccharide genes and flanking regions |
| US7018637B2 (en) | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| US7541043B2 (en) | 2002-01-16 | 2009-06-02 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine for protection against Shigella sonnei disease |
| IL163806A0 (en) | 2002-03-07 | 2005-12-18 | Eidgenoess Tech Hochschule | System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| ES2353814T3 (es) | 2005-05-11 | 2011-03-07 | Eth Zuerich | Proteinas n-glicosiladas recombinantes de celulas procariotas. |
| CN101983070B (zh) | 2008-02-20 | 2016-03-30 | 格林考瓦因有限公司 | 由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物 |
| JP5841044B2 (ja) * | 2009-03-23 | 2016-01-06 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． | 複合糖質ワクチン |
| JP2012533285A (ja) | 2009-07-17 | 2012-12-27 | オーシャン ハーベスト テクノロジー （カナダ） インコーポレイテッド | 魚用飼料中の合成添加物を置換する、天然かつ持続可能な海藻配合物 |
| EP3281639B1 (en) | 2010-05-06 | 2020-11-11 | GlaxoSmithKline Biologicals S.A. | Capsular gram-positive bacteria bioconjugate vaccines |
| ES2905107T3 (es) * | 2012-10-12 | 2022-04-07 | Glaxosmithkline Biologicals Sa | Procedimientos de modificación de células hospedadoras |
-
2013
- 2013-11-07 EP EP18211761.4A patent/EP3508579B1/en active Active
- 2013-11-07 TR TR2019/03066T patent/TR201903066T4/tr unknown
- 2013-11-07 ES ES18211761T patent/ES2882282T3/es active Active
- 2013-11-07 BR BR112015010283A patent/BR112015010283A8/pt not_active Application Discontinuation
- 2013-11-07 ES ES13788753T patent/ES2713166T3/es active Active
- 2013-11-07 WO PCT/EP2013/073266 patent/WO2014072405A1/en not_active Ceased
- 2013-11-07 JP JP2015541130A patent/JP6412875B2/ja not_active Expired - Fee Related
- 2013-11-07 EP EP18198665.4A patent/EP3444352B1/en active Active
- 2013-11-07 AU AU2013343520A patent/AU2013343520B2/en not_active Ceased
- 2013-11-07 EP EP13788753.5A patent/EP2917351B1/en active Active
- 2013-11-07 EA EA201590705A patent/EA201590705A1/ru unknown
- 2013-11-07 MX MX2015005797A patent/MX366912B/es active IP Right Grant
- 2013-11-07 CN CN201380069524.XA patent/CN105008539B/zh not_active Expired - Fee Related
- 2013-11-07 CA CA2889767A patent/CA2889767C/en active Active
- 2013-11-07 US US14/440,311 patent/US20150273043A1/en not_active Abandoned
- 2013-11-07 CA CA3125293A patent/CA3125293A1/en active Pending
- 2013-11-07 SG SG11201503308XA patent/SG11201503308XA/en unknown
- 2013-11-07 ES ES18198665T patent/ES2848774T3/es active Active
- 2013-11-07 KR KR1020157014830A patent/KR20150079964A/ko not_active Withdrawn
-
2015
- 2015-05-03 IL IL238586A patent/IL238586A0/en unknown
- 2015-05-06 ZA ZA2015/03097A patent/ZA201503097B/en unknown
-
2017
- 2017-12-20 AU AU2017279688A patent/AU2017279688B2/en not_active Ceased
-
2018
- 2018-07-13 US US16/034,906 patent/US10973901B2/en not_active Expired - Fee Related
- 2018-10-01 JP JP2018186302A patent/JP6833785B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015533511A5 (https=) | ||
| AU2017279688B2 (en) | Production of recombinant vaccine in e. coli by enzymatic conjugation | |
| Wen et al. | Bacterial capsules | |
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| JP2017036303A5 (https=) | ||
| JP6682451B2 (ja) | 改変型宿主細胞およびその使用 | |
| BR112014018815B1 (pt) | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis | |
| CN104902931A (zh) | 包含修饰的抗原的生物缀合物及其用途 | |
| CN104487086B (zh) | 无动物源的不含酒精的疫苗组合物及其制备方法 | |
| US10716839B2 (en) | Compositions and methods for producing bacterial conjugate vaccines | |
| US11596677B2 (en) | Induction of protective immunity against antigens | |
| Baliban et al. | Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS: FliC glycoconjugates in infant and adult mice | |
| CN110462020A (zh) | 针对抗原的保护性免疫的诱导 | |
| WO2006065137A2 (en) | Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria | |
| CN106110316A (zh) | 一种肺炎球菌结合物组合疫苗的制备方法 | |
| CN108774628B (zh) | 合成致新生儿脑膜炎大肠杆菌糖蛋白结合疫苗的大肠杆菌工程菌及用途 | |
| Schuster et al. | Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein | |
| ES2933027T3 (es) | Purificación de polisacáridos secretados de S. agalactiae | |
| JP7814103B2 (ja) | 糖の精製 | |
| Chan et al. | The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies | |
| Hosny et al. | Immune response to Vi polysaccharide, heat-killed whole cells, and outer membrane protein of Salmonella typhi | |
| MacLennan et al. | New Approaches for Needed Vaccines: Bacteria | |
| BR122024027321A2 (pt) | Composições imunogênicas de vacina | |
| HK40076438A (en) | Purification of saccharides | |
| RU2601158C1 (ru) | ШТАММЫ ВИДА Streptococcus pneumoniae (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ ИЗ НИХ ПРОТЕКТИВНОЙ БЕЛОКСОДЕРЖАЩЕЙ ФРАКЦИИ, ОБЛАДАЮЩЕЙ ВНУТРИВИДОВОЙ ИММУНОГЕННОЙ АКТИВНОСТЬЮ |